Journal of Addictive Diseases - The Consciousness Library

Breaking the cycle: a systematic review of neurobiological mechanisms and psychotherapeutic innovations in ketamine addiction.

Journal of Addictive Diseases March 6, 2025 Christopher Lomas 2 citations

This systematic review synthesizes current evidence on non-prescribed ketamine use, emphasizing its neurobiological impacts and psychotherapeutic interventions. Patterns of misuse demonstrate the complex interplay of neurobiological, socio-economic, demographic and psychological factors with adolescents, women and polysubstance users identified as high-risk groups. Neurobiological findings...

DOI: 10.1080/10550887.2025.2464356 Full text Substance abuse Treatment innovation Cbt Emdr +9

A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes.

Journal of Addictive Diseases January 20, 2025 Janice Chuang, Riley Carpenter Lide, Nikhil Kamath et al. 3 citations

There is increasing evidence of ketamine's therapeutic potential in reducing substance use in individuals with substance use disorders. However, its effects on tobacco use disorder are unknown. We investigated the effect of a subanesthetic dose of ketamine on tobacco use. This randomized, single-blind, placebo-controlled, pilot study administered intravenous ketamine to individuals with tobacco...

DOI: 10.1080/10550887.2025.2450129 Full text Ndma receptor antagonist Glutamate Tobacco Addiction treatment +4

A scoping review of spirituality in relation to substance use disorders: Psychological, biological, and cultural issues.

Journal of Addictive Diseases 2024 Marc Galanter, William L White, Jag Khalsa et al. 14 citations

Spirituality is a construct encompassing a diversity of strongly held beliefs and pursuits related to life's meaning and purpose. Empirical studies in key domains of spirituality related to substance use disorder (SUD) can be valuable in guiding research, and potentially clinical care. To conduct a scoping review of research on the psychological, biological, and cultural dimensions of...

DOI: 10.1080/10550887.2023.2174785 Full text Addiction Alcoholics anonymous Narcotics anonymous Spirituality +1

Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review.

Journal of Addictive Diseases 2024 Alexandra Arenson, Cynthia I Campbell, Ilan Remler 8 citations

The opioid epidemic and limited access to treatment for opioid withdrawal (OW) and opioid use disorder (OUD) has led individuals to seek alternative treatments. This narrative review aims to educate clinicians on the mechanisms of action, toxicity, and applications of psychoactive plant-based substances patients may be using to self-treat OUD and OW. We specifically discuss ayahuasca, ibogaine,...

DOI: 10.1080/10550887.2023.2195777 Full text Ayahuasca Ibogaine Opioid use disorder Psychedelic therapy +6

Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia

Journal of Addictive Diseases August 4, 2023 Ruzmayuddin Mamat, Rusdi Abd Rashid, Baharudin Ibrahim et al. 2 citations

Psilocybin in vaping is growing among ATS users and across all populations. Unfortunately, knowledge regarding the long-term effects on health is limited. Further studies should highlight the harmful effects of psilocybin and the potential risk of psilocybin vaping among the younger population.

DOI: 10.1080/10550887.2023.2240932 Psilocybin Cannabis Hallucinogen Amphetamine +1

Hallucinogenic mushroom misuse reported to Texas poison centers

Journal of Addictive Diseases May 18, 2020 Mathias B. Forrester 6 citations

BACKGROUND: Hallucinogenic mushrooms are fungi that contain the substance psilocybin. When ingested, psilocybin can induce hallucinations, euphoria, and alterations in the perception of space and time. Ingestion of hallucinogenic mushrooms may result in adverse effects. OBJECTIVE: The objective of this study was to describe hallucinogenic mushroom misuse reported to poison centers. METHODS:...

DOI: 10.1080/10550887.2020.1785817 Psilocybin Hallucinogen Poison control Euphoriant +4

Hallucinogen persisting perception disorder: A literature review and three case reports

Journal of Addictive Diseases October 2, 2018 Valentin Yurievich Skryabin, М.а. Винникова, A. Yu. Nenastieva et al. 27 citations

The paper describes diagnostic criteria, clinical presentation and types of hallucinogen persisting perception disorder (HPPD), as well as current approaches to the treatment of this phenomenon using available scientific sources. Three case reports are also presented to demonstrate different types of this disorder. The first case report describes a 23-year old patient with a previous history of...

DOI: 10.1080/10550887.2019.1673655 Ecstasy Cannabis MDMA Psilocybin +3

LSD Use and Flashbacks in Alcoholic Patients

Journal of Addictive Diseases April 5, 1999 Wayne Bemis Batzer, Thomas F. Ditzler, Christopher R. Brown 12 citations

Lysergic Acid Diethylamide (LSD) is a hallucinogenic drug that received considerable attention in the 1960's and early 1970's. It produced a wide variety of psychological phenomena, including a variety of perceptual disturbances which would manifest among some users long after the drug had left the system. These phenomena were commonly referred to as "flashbacks" and may have been largely...

DOI: 10.1300/j069v18n02_06 Lysergic acid diethylamide Psilocybin Hallucinogen Euphoriant +4

William James' legacy to Alcoholics Anonymous: an analysis and a critique.

Journal of Addictive Diseases 1992 A H Walle

When evolving a philosophy and a "modus operandi" the pioneers of Alcoholics Anonymous made significant use of William James' Varieties of Religious Experience. Indeed, although AA carefully picked and chose various of James' ideas which seemed particularly relevant, James' imprint is clearly stamped upon AA philosophy and methodology. Here, I will review James' work and explore what specific...

DOI: 10.1300/j069v11n03_06 Full text

Papers